Clinical trial

Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel…

NCT00130741 · Hadassah Medical Organization, Other · Completed

Key facts

NCT number NCT00130741
Title Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
Official title A Phase I, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of a Combination Herbal Therapy (CHT), Versus Placebo in Improving the Overall Quality of Life and Symptoms in Patients With Irritable Bowel Syndrome (IBS)
Lead sponsor Hadassah Medical Organization, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Colonic Diseases, Functional
Intervention type Drug
Interventions CHT - herbal therapy
Enrollment 100
Start date Jul 1, 2005
Completion Jan 1, 2007
First posted Aug 16, 2005
Last update posted Apr 11, 2007
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies